Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

[1]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  B. Milleron,et al.  IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  G. Watanabe,et al.  Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. , 2001, The Annals of thoracic surgery.

[4]  N. Goldstein,et al.  Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. , 2001, American journal of clinical pathology.

[5]  R. Wilson,et al.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Gaeta,et al.  Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study. , 2003, Lung cancer.

[7]  P. Pairolero,et al.  Bronchoalveolar carcinoma: factors affecting survival. , 1991, The Annals of thoracic surgery.

[8]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[9]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[10]  K. S. Lee,et al.  Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. , 2001, AJR. American journal of roentgenology.

[11]  H. Horinouchi,et al.  Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma , 2008, Modern Pathology.

[12]  A. Iafrate,et al.  Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. , 2007, The Journal of molecular diagnostics : JMD.

[13]  L. Chirieac,et al.  Prognostic significance of grading in lung adenocarcinoma , 2010, Cancer.

[14]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  Jungsil Ro,et al.  Micropapillary Component in Lung Adenocarcinoma: A Distinctive Histologic Feature With Possible Prognostic Significance , 2002, The American journal of surgical pathology.

[16]  Akihiko Yoshizawa,et al.  A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.

[17]  C. Foucault,et al.  Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. , 2006, The Annals of thoracic surgery.

[18]  Y. Nishiwaki,et al.  Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma. , 2010, Lung cancer.

[19]  H. Iwasaki,et al.  Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours) , 2005, Histopathology.

[20]  J. Austin,et al.  The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification , 2009 .

[21]  A. Marchetti,et al.  BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K‐ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE , 1996, The Journal of pathology.

[22]  S. Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis. , 1995, Cancer.

[23]  Ho Yun Lee,et al.  Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. , 2009, Lung cancer.

[24]  D. Garfield,et al.  Bronchioloalveolar carcinoma: the case for two diseases. , 2008, Clinical lung cancer.

[25]  Y. Ishikawa,et al.  Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor Prognosis , 2003, The American journal of surgical pathology.

[26]  M. Antoine,et al.  Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. , 2010, Lung cancer.

[27]  M. Hollingsworth,et al.  A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis , 2007, Modern Pathology.

[28]  H. Iwasaki,et al.  Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors , 2007, Modern Pathology.

[29]  W. Gerald,et al.  Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis , 2008, The American journal of surgical pathology.

[30]  D. Garfield,et al.  The Importance of Distinguishing Mucinous and Nonmucinous Bronchioloalveolar Carcinomas , 2009, Lung.

[31]  V. Rusch,et al.  Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  T. Mok,et al.  Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.

[33]  P. Boyle,et al.  World Cancer Report 2008 , 2009 .

[34]  J. Manning,et al.  Bronchioloalveolar carcinoma: The significance of two histopathologic types , 1984, Cancer.

[35]  F. Clayton.  Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates , 1986, Cancer.

[36]  Y. Yatabe,et al.  CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas , 2004, The Journal of pathology.